Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
This report elaborates on the current development of the Choroidal Neovascularization industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Gilead Sciences Inc
Promedior Inc
Sanwa Kagaku Kenkyusho Co Ltd
Bayer AG
Regeneron Pharmaceuticals Inc
Novartis AG
Valeant Pharmaceuticals International Inc
Pfizer Inc
F Hoffmann-La Roche Ltd
By Type:
Intravitreal
Intravenous
By Application:
Age-related Developments
Malignant Myopic Degeneration
Extreme Myopia
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Choroidal Neovascularization Market Overview 2018-2029
-
1.1 China Choroidal Neovascularization Industry Development Overview
-
1.2 China Choroidal Neovascularization Industry Development History
-
1.3 China Choroidal Neovascularization Industry Market Size (2018-2029)
-
1.4 China Choroidal Neovascularization Market Analysis by Type from Production Side
-
1.4.1 China Choroidal Neovascularization Production Volume, Production Value and Growth Rate of Intravitreal (2018-2029)
-
1.4.2 China Choroidal Neovascularization Production Volume, Production Value and Growth Rate of Intravenous (2018-2029)
-
1.5 China Choroidal Neovascularization Market Analysis by Application from Consumption End
-
1.5.1 China Choroidal Neovascularization Sales Volume, Sales Value and Growth Rate of Age-related Developments (2018-2029)
-
1.5.2 China Choroidal Neovascularization Sales Volume, Sales Value and Growth Rate of Malignant Myopic Degeneration (2018-2029)
-
1.5.3 China Choroidal Neovascularization Sales Volume, Sales Value and Growth Rate of Extreme Myopia (2018-2029)
-
1.6 China Choroidal Neovascularization Market Analysis by Region
-
1.6.1 North China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
Chapter 2 China Choroidal Neovascularization Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Choroidal Neovascularization Market Status and Competition at home and abroad in 2023
-
2.2.2 China Choroidal Neovascularization Market Status and Competition Analysis in 2023
-
2.2.3 China Choroidal Neovascularization Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Choroidal Neovascularization Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Choroidal Neovascularization Industry Development
Chapter 3 Choroidal NeovascularizationIndustry Chain Analysis
-
3.1 Choroidal Neovascularization Industry Chain
-
3.2 Choroidal Neovascularization Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Choroidal Neovascularization Market
-
3.3 Choroidal Neovascularization Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Choroidal Neovascularization Market
Chapter 4 China Choroidal Neovascularization Market, by Type
-
4.1 China Choroidal Neovascularization Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Choroidal Neovascularization Total Production Volume and Growth Rate from Production Side
-
4.5 China Choroidal Neovascularization Production Volume and Growth Rate, by Type
-
4.5.1 China Choroidal Neovascularization Production Volume and Growth Rate of Intravitreal
-
4.5.2 China Choroidal Neovascularization Production Volume and Growth Rate of Intravenous
Chapter 5 China Choroidal Neovascularization Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Choroidal Neovascularization Total Market Size and Growth Rate from Consumption End
-
5.5 China Choroidal Neovascularization Market Size and Growth Rate, by Application
-
5.5.1 China Choroidal Neovascularization Market Size and Growth Rate of Age-related Developments
-
5.5.2 China Choroidal Neovascularization Market Size and Growth Rate of Malignant Myopic Degeneration
-
5.5.3 China Choroidal Neovascularization Market Size and Growth Rate of Extreme Myopia
Chapter 6 China Choroidal Neovascularization Market, by Region
-
6.1 China Choroidal Neovascularization Production Volume and Production Value, by Region
-
6.2 China Choroidal Neovascularization Sales Volume and Sales Value, by Region
Chapter 7 North China Choroidal Neovascularization Market Analysis
-
7.1 North China Choroidal Neovascularization Market, by Type
-
7.2 North China Choroidal Neovascularization Market, by Application
Chapter 8 Central China Choroidal Neovascularization Market Analysis
-
8.1 Central China Choroidal Neovascularization Market, by Type
-
8.2 Central China Choroidal Neovascularization Market, by Application
Chapter 9 South China Choroidal Neovascularization Market Analysis
-
9.1 South China Choroidal Neovascularization Market, by Type
-
9.2 South China Choroidal Neovascularization Market, by Application
Chapter 10 East China Choroidal Neovascularization Market Analysis
-
10.1 East China Choroidal Neovascularization Market, by Type
-
10.2 East China Choroidal Neovascularization Market, by Application
Chapter 11 Northeast China Choroidal Neovascularization Market Analysis
-
11.1 Northeast China Choroidal Neovascularization Market, by Type
-
11.2 Northeast China Choroidal Neovascularization Market, by Application
Chapter 12 Southwest China Choroidal Neovascularization Market Analysis
-
12.1 Southwest China Choroidal Neovascularization Market, by Type
-
12.2 Southwest China Choroidal Neovascularization Market, by Application
Chapter 13 Northwest China Choroidal Neovascularization Market Analysis
-
13.1 Northwest China Choroidal Neovascularization Market, by Type
-
13.2 Northwest China Choroidal Neovascularization Market, by Application
Chapter 14 Company Profiles
-
14.1 Gilead Sciences Inc
-
14.1.1 Gilead Sciences Inc Company Profile
-
14.1.2 Gilead Sciences Inc Choroidal Neovascularization Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Promedior Inc
-
14.2.1 Promedior Inc Company Profile
-
14.2.2 Promedior Inc Choroidal Neovascularization Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sanwa Kagaku Kenkyusho Co Ltd
-
14.3.1 Sanwa Kagaku Kenkyusho Co Ltd Company Profile
-
14.3.2 Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Bayer AG
-
14.4.1 Bayer AG Company Profile
-
14.4.2 Bayer AG Choroidal Neovascularization Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Regeneron Pharmaceuticals Inc
-
14.5.1 Regeneron Pharmaceuticals Inc Company Profile
-
14.5.2 Regeneron Pharmaceuticals Inc Choroidal Neovascularization Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Profile
-
14.6.2 Novartis AG Choroidal Neovascularization Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Valeant Pharmaceuticals International Inc
-
14.7.1 Valeant Pharmaceuticals International Inc Company Profile
-
14.7.2 Valeant Pharmaceuticals International Inc Choroidal Neovascularization Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Pfizer Inc
-
14.8.1 Pfizer Inc Company Profile
-
14.8.2 Pfizer Inc Choroidal Neovascularization Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 F Hoffmann-La Roche Ltd
-
14.9.1 F Hoffmann-La Roche Ltd Company Profile
-
14.9.2 F Hoffmann-La Roche Ltd Choroidal Neovascularization Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Choroidal Neovascularization Industry Research Conclusions
-
15.2 Choroidal Neovascularization Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Choroidal Neovascularization Industry Market Size (2018-2029)
-
Figure China Choroidal Neovascularization Production Volume, Production Value and Growth Rate of Intravitreal (2018-2029)
-
Figure China Choroidal Neovascularization Production Volume, Production Value and Growth Rate of Intravenous (2018-2029)
-
Figure China Choroidal Neovascularization Sales Volume, Sales Value and Growth Rate of Age-related Developments (2018-2029)
-
Figure China Choroidal Neovascularization Sales Volume, Sales Value and Growth Rate of Malignant Myopic Degeneration (2018-2029)
-
Figure China Choroidal Neovascularization Sales Volume, Sales Value and Growth Rate of Extreme Myopia (2018-2029)
-
Figure North China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
Figure Central China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
Figure South China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
Figure East China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Choroidal Neovascularization Market Size and Growth Rate from 2018-2029
-
Figure Choroidal Neovascularization Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Choroidal Neovascularization Market Share by Type in 2018
-
Figure China Choroidal Neovascularization Market Share by Type in 2023
-
Figure China Choroidal Neovascularization Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Choroidal Neovascularization Production Volume and Growth Rate of Intravitreal (2018-2023)
-
Figure China Choroidal Neovascularization Production Volume and Growth Rate of Intravenous (2018-2023)
-
Figure China Choroidal Neovascularization Market Share by Application in 2018
-
Figure China Choroidal Neovascularization Market Share by Application in 2023
-
Figure China Choroidal Neovascularization Total Market Size and Growth Rate from Consumption End
-
Figure China Choroidal Neovascularization Market Size and Growth Rate of Age-related Developments (2018-2023)
-
Figure China Choroidal Neovascularization Market Size and Growth Rate of Malignant Myopic Degeneration (2018-2023)
-
Figure China Choroidal Neovascularization Market Size and Growth Rate of Extreme Myopia (2018-2023)
-
Table China Choroidal Neovascularization Production Volume by Region (2018-2023)
-
Table China Choroidal Neovascularization Production Volume Share by Region (2018-2023)
-
Figure China Choroidal Neovascularization Production Volume Share by Region (2018-2023)
-
Table China Choroidal Neovascularization Production Value by Region (2018-2023)
-
Table China Choroidal Neovascularization Production Value Share by Region (2018-2023)
-
Figure China Choroidal Neovascularization Production Value Share by Region (2018-2023)
-
Table China Choroidal Neovascularization Sales Volume by Region (2018-2023)
-
Table China Choroidal Neovascularization Sales Volume Share by Region (2018-2023)
-
Figure China Choroidal Neovascularization Sales Volume Share by Region (2018-2023)
-
Table China Choroidal Neovascularization Sales Value by Region (2018-2023)
-
Table China Choroidal Neovascularization Sales Value Share by Region (2018-2023)
-
Figure China Choroidal Neovascularization Sales Value Share by Region (2018-2023)
-
Table North China Choroidal Neovascularization Production Volume by Type (2018-2023)
-
Table North China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Figure North China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Table North China Choroidal Neovascularization Sales Volume by Application (2018-2023)
-
Table North China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Figure North China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Table Central China Choroidal Neovascularization Production Volume by Type (2018-2023)
-
Table Central China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Figure Central China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Table Central China Choroidal Neovascularization Sales Volume by Application (2018-2023)
-
Table Central China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Figure Central China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Table South China Choroidal Neovascularization Production Volume by Type (2018-2023)
-
Table South China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Figure South China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Table South China Choroidal Neovascularization Sales Volume by Application (2018-2023)
-
Table South China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Figure South China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Table East China Choroidal Neovascularization Production Volume by Type (2018-2023)
-
Table East China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Figure East China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Table East China Choroidal Neovascularization Sales Volume by Application (2018-2023)
-
Table East China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Figure East China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Table Northeast China Choroidal Neovascularization Production Volume by Type (2018-2023)
-
Table Northeast China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Figure Northeast China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Table Northeast China Choroidal Neovascularization Sales Volume by Application (2018-2023)
-
Table Northeast China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Table Southwest China Choroidal Neovascularization Production Volume by Type (2018-2023)
-
Table Southwest China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Figure Southwest China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Table Southwest China Choroidal Neovascularization Sales Volume by Application (2018-2023)
-
Table Southwest China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Table Northwest China Choroidal Neovascularization Production Volume by Type (2018-2023)
-
Table Northwest China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Figure Northwest China Choroidal Neovascularization Production Volume Share by Type (2018-2023)
-
Table Northwest China Choroidal Neovascularization Sales Volume by Application (2018-2023)
-
Table Northwest China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Choroidal Neovascularization Sales Volume Share by Application (2018-2023)
-
Table Gilead Sciences Inc Company Profile
-
Table Gilead Sciences Inc Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table Promedior Inc Company Profile
-
Table Promedior Inc Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table Sanwa Kagaku Kenkyusho Co Ltd Company Profile
-
Table Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table Regeneron Pharmaceuticals Inc Company Profile
-
Table Regeneron Pharmaceuticals Inc Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table Valeant Pharmaceuticals International Inc Company Profile
-
Table Valeant Pharmaceuticals International Inc Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Choroidal Neovascularization Revenue, Price and Gross (2018-2023)
-
